MONTE ROSA THERAPEUTICS
(NASDAQ: GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

8.900

+0.400 (+4.71%)
Range 8.310 - 8.940   (7.58%)
Open 8.350
Previous Close 8.500
Bid Price 6.270
Bid Volume 9
Ask Price 6.340
Ask Volume 9
Volume 744,461
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis